Leucadia National - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Leucadia National ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$567,796
+334.5%
570,000
+328.6%
0.01%
+400.0%
Q4 2022$130,673133,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 90,815,000$90,802,6815.68%
PIPER SANDLER & CO. 6,695,000$6,694,0634.58%
Opti Capital Management, LP 46,902,000$46,902,0003.79%
Monashee Investment Management LLC 9,000,000$8,975,1602.48%
TENOR CAPITAL MANAGEMENT Co., L.P. 96,994,000$97,297,0841.93%
DeepCurrents Investment Group LLC 41,092,000$40,966,1771.60%
Sonora Investment Management Group, LLC 9,395,000$9,387,5820.82%
Penn Mutual Asset Management, LLC 675,000$677,0180.64%
OAKTREE CAPITAL MANAGEMENT LP 19,540,000$19,586,1990.22%
BRAIDWELL LP 6,500,000$6,515,3680.22%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders